The board of directors of Sihuan Pharmaceutical Holdings Group Ltd. announced that in order to comply with the forthcoming amendments to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited which will be effective on April 1, 2012, Dr. Che Fengsheng ceased to be the chairman of the remuneration committee of the company and Mr. Bai Huiliang, an independent non-executive Director, was appointed as the chairman of the Remuneration Committee with effect from March 19, 2012. Dr. Che remains as a member of the Remuneration Committee. Further, Dr. Guo Weicheng ceased to be the chairman of the nomination committee of the company and Mr. Xu Kangsen, an independent non-executive Director, was appointed as the chairman of the Nomination Committee with effect from March 19, 2012. Dr. Guo remains as a member of the Nomination Committee.